News
News
- NGM Bio Presents Comprehensive Findings from 24-Week Phase 2 Study (Cohort 4) of Aldafermin in Oral Plenary Presentation at The Digital International Liver Congress™ (ILC) 2020 and Announces Enrollment Completed in Phase 2b ALPINE 2/3 Study
08/29/2020 / 13:20 - GlobeNewswire - VASCEPA® (Icosapent Ethyl) Reported to Significantly Reduce Coronary Plaque in EVAPORATE Study Final Results Presented at ESC Congress 2020
08/29/2020 / 09:13 - GlobeNewswire - Matinas BioPharma Completes Enrollment of ENHANCE-IT Study of MAT9001 Against Vascepa®
08/27/2020 / 22:05 - GlobeNewswire - RedHill Biopharma Announces Positive Recommendation from Independent Committee to Continue U.S. Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy
08/27/2020 / 13:00 - GlobeNewswire - Gitpod Fundamentally Changes Development Workflows with the Industry’s First Open Source Solution for Automated, Pre-built Dev Environments
08/25/2020 / 15:00 - GlobeNewswire - Philips and B. Braun receive FDA clearance for breakthrough Onvision needle tip tracking technology for regional anesthesia
08/25/2020 / 15:00 - GlobeNewswire - Albireo Reports Topline Results from Phase 2 Trial of Elobixibat in NAFLD/NASH
08/18/2020 / 22:40 - GlobeNewswire - Homeschool Experts Recommend Camping as Virtual Learning Tool
08/18/2020 / 15:30 - GlobeNewswire - David McGill Joins Avineon as Vice President, Growth Operations
08/18/2020 / 14:00 - GlobeNewswire - LexinFintech Holdings Ltd. Announces Changes to Board of Directors
08/18/2020 / 09:14 - GlobeNewswire
Real-time